20 Results for "

EPAC1

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "EPAC1" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-16704
CAS No.: 263707-16-0
Target:  

Virus Protease

Domaines de recherche:  

Cancer

ESI-09 is a novel noncyclic nucleotide EPAC antagonist with IC50 values of 3.2 and 1.4 μM for EPAC1 and EPAC2, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108539
CAS No.: 143703-25-7
Pureté:  95.68%
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease

CE3F4 is a selective antagonist of exchange protein directly activated by cAMP (Epac1), with IC50s of 10.7 μM and 66 μM for Epac1 and Epac2(B), respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107543
CAS No.: 634207-53-7
Pureté:  99.81%
Synonyms: 8-CPT-2'-O-Me-cAMP sodium
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease

8-pCPT-2′-O-Me-cAMP (8-CPT-2'-O-Me-cAMP) sodium, an analog of cAMP, is an activator of exchange proteins activated by cAMP (Epac). 8-pCPT-2′-O-Me-cAMP sodium activates Epac1 (EC50 = 2.2 μM), but not PKA (EC50 >10 μM). 8-pCPT-2′-O-Me-cAMP sodium stimulates Epac-mediated Ca 2+ release in pancreatic β-cells in vitro. 8-pCPT-2′-O-Me-cAMP sodium is a Rap1 activator. 8-pCPT-2′-O-Me-cAMP sodium enhances the retinal pigment epithelium barrier against the pathological choroidal endothelial cell invasion that occurs in macular degeneration [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136172
CAS No.: 301177-43-5
Pureté:  98.74%
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease Metabolic Disease Cancer

ESI-08 is a potent and selective EPAC antagonist, which can completely inhibit both EPAC1 and EPAC2 (IC50 of 8.4 μM) activity. ESI-08 selectively blocks cAMP-induced EPAC activation, but does not inhibit cAMP-mediated PKA activation [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117958
CAS No.: 1383539-73-8
Pureté:  99.62%
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease Metabolic Disease Cancer

HJC0197 is a potent Epac1 (exchange protein directly activated by cAMP 1) and Epac2 (IC50=5.9 μM for Epac2) antagonist. HJC0197 selectively blocks cAMP-induced Epac activation. HJC0197 inhibits Epac1-mediated Rap1-GDP exchange activity at 25 μM in the presence of equal concentration of cAMP [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108539A
CAS No.: 1593478-56-8
Pureté:  ≥99.0%
Target:  

Ras

Domaines de recherche:  

Metabolic Disease

(R)-CE3F4 is a potent and selective inhibitor of exchange protein directly activated by cAMP isoform 1 (Epac1), with an IC50 of 4.2 μM, with 10-fold selectivity for Epac1 over Epac2 (IC50, 44 μM). (R)-CE3F4 is more potent than racemic CE3F4 and (S)-CE3F4 [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80120

Host:  

Rabbit

Application:  

WB, IHC-P, IP, ICC/IF

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-126133
CAS No.: 340817-81-4
Pureté:  99.95%
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease Others

AM-001 is a non-competitive inhibitor of Epac1 that blocks the activation of Rap1, a downstream effector of Epac1, in cultured cells. AM-001 can be used in heart disease-related research [1].
loading...
    loading...
Cat. No.: HY-129738
CAS No.: 868145-09-9
Pureté:  99.38%
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease

I942 is a first in class, selective non-cyclic nucleotide (NCN) EPAC1 agonist. I942 can attenuate proinflammatory cytokine signalling normally associated with cardiovascular diseases [1].
loading...
    loading...
Cat. No.: HY-111446
CAS No.: 302826-61-5
Pureté:  98.10%
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease Metabolic Disease Cancer

EPAC 5376753, a 2-Thiobarbituric acid (HY-77962) derivative, is a selective and allosteric Epac inhibitor. EPAC 5376753 inhibits Epac1 with an IC50 of 4 µM in Swiss 3T3 cells. EPAC 5376753 does not inhibit PKA and adenylyl cyclases [1].
loading...
    loading...
Cat. No.: HY-134299
CAS No.: 663941-66-0
Synonyms: 8-(4-Chlorophenylthio)-cAMP-AM
Target:  

Ras PKA

Domaines de recherche:  

Cardiovascular Disease Metabolic Disease Cancer

8-CPT-cAMP-AM (8-(4-Chlorophenylthio)-cAMP-AM) is an Epac/PKA activator. 8-CPT-cAMP-AM potentiates glucose-dependent first- and second-phase insulin secretion, induces β-cell depolarization, modulates intracellular calcium via influx and ryanodine-sensitive store mobilization, and facilitates calcium-induced calcium release resistant to PKA inhibition. 8-CPT-cAMP-AM can be used for the research of cardiac hypertrophy, diabetic cardiomyopathy, and melanoma [1] .
loading...
    loading...
Cat. No.: HY-116312
CAS No.: 510774-50-2
Synonyms: 8-CPT-2'-O-Me-cAMP
Target:  

Ras

Domaines de recherche:  

Cardiovascular Disease

8-pCPT-2′-O-Me-cAMP (8-CPT-2'-O-Me-cAMP), an analog of cAMP, is an activator of exchange proteins activated by cAMP (Epac). 8-pCPT-2′-O-Me-cAMP activates Epac1 (EC50 = 2.2 μM), but not PKA (EC50 >10 μM). 8-pCPT-2′-O-Me-cAMP stimulates Epac-mediated Ca 2+ release in pancreatic β-cells in vitro. 8-pCPT-2′-O-Me-cAMP is a Rap1 activator. 8-pCPT-2′-O-Me-cAMP enhances the retinal pigment epithelium barrier against the pathological choroidal endothelial cell invasion that occurs in macular degeneration [1] .
loading...
    loading...
Cat. No.: HY-117064
CAS No.: 1801911-86-3
Target:  

Ras

Domaines de recherche:  

Others

NY-0173 is an antagonist of Exchange proteins directly activated by cAMP (EPAC), with IC50s of 3.5 μM (EPAC2)and 4.0 μM (EPAC1) respectively. NY-0173 can be used to elucidate the biological functions of EPAC .
loading...
    loading...
Cat. No.: HY-134308
CAS No.: 221905-51-7
Target:  

Fluorescent Dye

Domaines de recherche:  

Others

8-NBD-cAMP sodium is a fluorescently labeled cyclic adenosine phosphate (cAMP) analogue. 8-NBD-cAMP sodium retains a similar biological activity to cAMP, regulating their activity by binding to specific proteins such as EPACs or PKA. 8-NBD-cAMP sodium can be used in fluorescent competitive binding experiments to evaluate the binding affinity of newly synthesized EPAC1 agonists to EPAC1 proteins [1].
loading...
    loading...
Cat. No.: HY-182273
CAS No.: 3106606-59-8
Target:  

STAT Acyltransferase

Domaines de recherche:  

Others

DM243 is an EPAC1 activator and STAT3 modulator with an pIC50 of 4.769 for EPAC1. DM243 increases GTP-bound Rap1 levels in EPAC1-expressing cells. DM243 reduces IL-6/IL-6Rα-evoked STAT3 phosphorylation in endothelial cells. DM243 suppresses TGF-β1-induced fibroblast-to-myofibroblast transition, reducing α-smooth muscle actin and Collagen I levels in lung fibroblasts. DM243 exhibits minimal cytotoxicity in normal human lung fibroblasts [1].
loading...
    loading...
Cat. No.: HY-123795
CAS No.: 1801911-70-5
Target:  

Ras Akt ERK VEGFR

Domaines de recherche:  

Cancer

NY0123 is a EPAC1 inhibitor. NY0123 significantly inhibits the expression of EPAC1, phosphorylated AKT, phosphorylated ERK1/2 and phosphorylated VEGFR2. NY0123 inhibits angiogenesis and tumor growth of triple-negative breast cancer. NY0123 is applicable to relevant research on triple-negative breast cancer [1].
loading...
    loading...
Cat. No.: HY-182274
CAS No.: 3106606-60-1
Target:  

Acyltransferase STAT

Domaines de recherche:  

Others

DM245 is an EPAC1 activator and STAT3 phosphorylation inhibitor with a target pIC50 of 4.801. DM245 activates EPAC1 to increase Rap1-GTP levels, with no activation of EPAC2 or PKA. DM245 reduces IL-6/IL-6Rα-evoked STAT3 phosphorylation in endothelial cells. DM245 suppresses TGF-β1-induced fibroblast-to-myofibroblast transition, reducing αSMA and Collagen I levels. DM245 exhibits minimal cytotoxicity in normal human lung fibroblasts, with negligible loss of intact nuclei after 72 h exposure [1].
loading...
    loading...
Cat. No.: HY-108539R
CAS No.: 143703-25-7
Target:  

Reference Standards Ras

Domaines de recherche:  

Cardiovascular Disease

CE3F4 (Standard) is the analytical standard of CE3F4 (HY-108539). This product is intended for research and analytical applications. CE3F4 is a selective antagonist of exchange protein directly activated by cAMP (Epac1), with IC50s of 10.7 μM and 66 μM for Epac1 and Epac2(B), respectively.
loading...
    loading...
Cat. No.: HY-RS11662
Domaines de recherche:  

Others

RAPGEF3 Human Pre-designed siRNA Set A contains three designed siRNAs for RAPGEF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-107543R
CAS No.: 634207-53-7
Synonyms: 8-CPT-2'-O-Me-cAMP sodium (Standard)
Target:  

Reference Standards Ras

Domaines de recherche:  

Cardiovascular Disease

8-pCPT-2′-O-Me-cAMP sodium (Standard) is the analytical standard of 8-pCPT-2′-O-Me-cAMP (sodium) (HY-107543). This product is intended for research and analytical applications. 8-pCPT-2′-O-Me-cAMP (8-CPT-2'-O-Me-cAMP) sodium, an analog of cAMP, is an activator of exchange proteins activated by cAMP (Epac). 8-pCPT-2′-O-Me-cAMP sodium activates Epac1 (EC50 = 2.2 μM), but not PKA (EC50 >10 μM). 8-pCPT-2′-O-Me-cAMP sodium stimulates Epac-mediated Ca2+ release in pancreatic β-cells in vitro. 8-pCPT-2′-O-Me-cAMP sodium is a Rap1 activator. 8-pCPT-2′-O-Me-cAMP sodium enhances the retinal pigment epithelium barrier against the pathological choroidal endothelial cell invasion that occurs in macular degeneration [1] .
loading...
    loading...
  • 1